AIIMS Director Dr Guleria expressed hope that vaccine should be available by the end of this month or early next month.
COVID VACCINE IN INDIA
NEW DELHI: India could be looking at making available a COVID-19 vaccine as early as January, says All India Institute of Medical Sciences (AIIMS) Director Randeep Guleria, while saying that what matters the most is safety and efficacy and not being the first off the block.
“In the beginning, the vaccine won’t be available in sufficient doses to give to everyone. We need a priority list to see that we vaccinate those who’ve high chances of dying due to Covid. Elderly, people with comorbidities and front line workers should be vaccinated first.
Two vaccines in India are in their third phase of testing, and we are hopeful that by January, we should be able to get emergency use authorisation.” Dr Guleria said.
However, Serum Institute of India, the clinical trial sponsor of the ‘Covishield’ vaccine in India, called the allegations in the notice “malicious and misconceived” and has threatened to seek damages over Rs 100 crore.
The company said that while it is comforting to the volunteer’s medical condition, there is no connection between the vaccine trial and the medical condition of the volunteer.